Home > Insider Trading > Filing (0001209191-15-005339)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1466301	Clovis Oncology Inc.	CLVS	Pharmaceutical Preparations (2834)	900475355

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1374539	R Andrew Allen	C/O Clovis Oncology, Inc. 2525 28Th Street, Suite 100 Boulder CO 80301	See Remarks	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2015-01-15	300	$65.00	181,619	No	4	S	Direct
Common Stock	Disposition	2015-01-16	30,524	$65.27	151,095	No	4	S	Direct
Common Stock	Disposition	2015-01-16	49,176	$65.88	101,919	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2014.
The price reported reflects the weighted average sale price. The shares of Common Stock were purchased in multiple transactions at prices ranging from $65.00 to $65.94, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported reflects the weighted average sale price. The shares of Common Stock were purchased in multiple transactions at prices ranging from $66.01 to $67.00, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.